KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

VivoSim Labs (VIVS) Gains from Investment Securities (2016 - 2023)

VivoSim Labs (VIVS) has 14 years of Gains from Investment Securities data on record, last reported at -$9000.0 in Q1 2023.

  • For Q1 2023, Gains from Investment Securities fell 100.4% year-over-year to -$9000.0; the TTM value through Mar 2023 reached $2.2 million, down 2.35%, while the annual FY2023 figure was -$9000.0, 100.39% down from the prior year.
  • Gains from Investment Securities reached -$9000.0 in Q1 2023 per VIVS's latest filing, down from $2.3 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $2.3 million in Q1 2022 and bottomed at -$24000.0 in Q4 2019.
  • Average Gains from Investment Securities over 5 years is $192000.0, with a median of $1000.0 recorded in 2020.
  • Peak YoY movement for Gains from Investment Securities: tumbled 166.67% in 2019, then skyrocketed 225400.0% in 2022.
  • A 5-year view of Gains from Investment Securities shows it stood at -$24000.0 in 2019, then soared by 104.17% to $1000.0 in 2020, then changed by 0.0% to $1000.0 in 2021, then surged by 225400.0% to $2.3 million in 2022, then tumbled by 100.4% to -$9000.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were -$9000.0 in Q1 2023, $2.3 million in Q1 2022, and $1000.0 in Q4 2021.